^○Michael Hall , Vicky Birks , Jenny Lewis , Sebastian Lopez , Stephanie Geoffroy , Carina Cantrill , Richard Cole (In Vitro and DDI Services, Quotient Bioresearch (Rushden) Ltd.)

^○Yukiko Sakakibara , Miki Katoh , Yuya Kondo , Masayuki Nadai (Faculty of Pharmacy, Meijo University)

^○Yuki Asai , Miki Katoh , Yukiko Sakakibara , Masayuki Nadai (Faculty of pharmacy, Meijo University)

^○Takaya Kutsukake ¹, Yoichi Furukawa ¹, Yukiko Kato ², Saki Gotoh ¹, Tatsuki Fukami ¹, Miki Nakajima ¹ (1.Faculty of Pharmaceutical Sciences, Kanazawa University, 2.Nagoya University)

^○Ryoichi Fujiwara , Yuki Kutsuno , Tomoo Itoh (Department of Pharmaceutics, School of Pharmacy, Kitasato University)

^○Wataru Habano , Jun Terashima , Shogo Ozawa (Department of Pharmacodynamics and Molecular Genetics, School of Pharmacy, Iwate Medical University)

^○Naoyuki Tatsumi , Shinsaku Tokumitsu , Tatsuki Fukami , Miki Nakajima (Faculty of Pharmaceutical Sciences, Kanazawa University)

^○Yuji Shirai ¹, Shingo Oda ¹, Sayaka Makino ¹, Koichi Tsuneyama ², Tsuyoshi Yokoi ¹ (1.Laboratory of Drug Safety Sciences, Division of Clinical Pharmacology, Nagoya University Graduate School of Medicine, 2.Department of Molecular and Environmental Pathology, Institute of Health Biosciences Tokushima University Graduate School)

^○Akira Nakajima , Shingo Oda , Tsuyoshi Yokoi (Laboratory of Drug Safety Sciences, Division of Clinical Pharmacology, Nagoya University of Graduate School of Medicine)

^○Takafumi Nakano ¹, Kazuma Hamada ¹, Kyoji Moriya ², Kazuhiko Koike ², Toshiharu Horie ¹ (1.Biopharmaceutics and Molecular Toxicology Unit, Faculty of Pharmaceutical Sciences, Teikyo Heisei University, 2.Department of Internal Medicine, Graduate School of Medicine, The University of Tokyo)

^○Shingo Oda , Toshio Seiki , Tsuyoshi Yokoi (Laboratory of Drug Safety Sciences, Division of Clinical Pharmacology, Nagoya University Graduate School of Medicine)

^○Cong Liu , Shigeki Aoki , Kotaro Kogo , Sota Fujimori , Shuichi Sekine , Kousei Ito (Laboratory of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Chiba University)

^○Ryuta Saito ^1,3, Jun Hasegawa ², Keigo Kosaka ³, Nao Torimoto ¹, Toshinobu Shimizu ² (1.Biology Research Laboratories, Research Core Unit, Mitsubishi Tanabe Pharma CO., 2.Safety Research Laboratories, Research Core Unit, Mitsubishi Tanabe Pharma CO., 3.DMPK Research Laboratories, Research Core Unit, Mitsubishi Tanabe Pharma CO.)

^○Akinori Takemura , Aya Izaki , Shuichi Sekine , Kousei Ito (The Laboratory of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Chiba University)

^○Katsuhito Watanabe ¹, Atsushi Iwamura ¹, Sho Akai ¹, Tsubasa Nishinosono ¹, Koichi Tsuneyama ², Shingo Oda ¹, Tsuyoshi Yokoi ¹ (1.Laboratory of Drug Safety Sciences, Division of Clinical Pharmacology, Nagoya University Graduate School of Medicine, 2.Department of Molecular and Environmental Pathology, Institute of Health Biosciences Tokushima University Graduate School)

^○Kouichi Yoshinari ¹, Hiroyuki Nakajima ² (1.Department of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka, 2.School of Pharmaceutical Sciences, Tohoku University)

^○Susumu Kodama ¹, Takuto Shimura ¹, Hideaki Kuribayashi ¹, Kouichi Yoshinari ^1,2 (1.Graduate School of Pharmaceutical Sciences, Tohoku University, 2.School of Pharmaceutical Sciences, University of Shizuoka)

^○Kenichiro Ogura , Jun Kinoshita , Tomokazu Ohnuma , Takahito Nishiyama , Akira Hiratsuka (Department of Drug Metabolism and Molecular Toxicology, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences)

^○Keisuke Hara ¹, Atsuyoshi Okada ², Tetsuya Aiba ¹ (1.Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama University, 2.Faculty of Pharmaceutical Science, Okayama University)

^○Shuko Hakata ¹, Wataru Habano ¹, Koji Okada ^1,2, Jun Terashima ¹, Shogo Ozawa ¹ (1.Graduate School of Pharmaceutical and Health Sciences, Iwate Medical University, 2.Department of Pharmacy, Iwate Prefectural Central Hospital)

^○Yuichi Ichimura , Kohei Kitamura , Takumi Akao , Sho Watanuki , Takashi Murabe , Masako Oda , Hiroshi Saito (Department of Pharmaceutics, School of Pharmaceutical Sciences, Health Sciences University of Hokkaido)

^○Yuuta Tominaga ¹, Kaori Morimoto ¹, Masanari Miyamoto ¹, Shota Kashiwagura ¹, Akira Takahashi ¹, Yoshimi Sano ¹, Kentaro Yano ², Takuo Ogihara ², Mikio Tomita ¹ (1.Tohoku pharmaceutical university, 2.Takasaki university of health and welfare, Faculty of pharmacy)

^○Kosuke Saito ¹, Keiko Maekawa ¹, Jason Kinchen ³, Yuji Kumagai ², Yoshiro Saito ¹ (1.Division of Medicinal Safety Science, National Institute of Health Sciences, 2.Clinical Research Center, Kitasato University, 3.Metabolon, Inc.)

^○Takashi Okura , Kei Higuchi , Manami Ueno , Hironao Ito , Asami Kondo , Yoshiharu Deguchi (Faculty of Pharma-Sciences, Teikyo University)

^○Wataru Ochiai , Ryosuke Miki , Haruka Kato , Yuya Nakajo , Ryuki Iimura , Satoshi Kitaoka , Nobutomo Ikarashi , Kiyoshi Sugiyama (Department of Clinical Pharmacokinetics, School of Pharmacy and Pharmaceutical Sciences, Hoshi University)